LINC-PINT and sarcoma: Conversely, in Lung Adenocarcinoma (LUAD), Pancreatic Adenocarcinoma (PAAD), Sarcoma (SARC), and Skin Cutaneous Melanoma (SKCM), LINC-PINT assumed the role of a favorable gene (HR < 1, P < 0.05), thereby demonstrating an encouraging association with improved OS outcomes (Fig. 6A).